Bioventus (BVS) Receivables - Other (2020 - 2025)
Bioventus (BVS) posted Receivables - Other of $177000.0 for Q4 2025, up 132.89% on a QoQ basis from $76000.0 in Q4 2024, and up 132.89% year-over-year from $76000.0 in Q4 2024.
Bioventus (BVS) Receivables - Other (2020 - 2025) Analysis & Trends
Bioventus' Receivables - Other history runs 6 years deep, the most recent figure standing at $177000.0 for Q4 2025.
- Quarterly Receivables - Other rose 132.89% year-over-year to $177000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $177000.0 (up 132.89% YoY) and the FY2025 annual result came in at $177000.0, up 132.89% from the prior year.
- Receivables - Other was $177000.0 for Q4 2025 at Bioventus, up from $76000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $6.5 million in Q3 2024 and bottomed at $76000.0 in Q4 2024.
- A 5-year average of $1.2 million and a median of $217000.0 in 2023 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2022 — Receivables - Other soared 326.83% — and 2024, when it tumbled 70.43%.
- Bioventus' Receivables - Other stood at $82000.0 in 2021, then jumped by 326.83% to $350000.0 in 2022, then fell by 26.57% to $257000.0 in 2023, then slumped by 70.43% to $76000.0 in 2024, then surged by 132.89% to $177000.0 in 2025.
- Business Quant data shows BVS's Receivables - Other at $177000.0 in Q4 2025, $76000.0 in Q4 2024, and $6.5 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn |
| 10 | Bioventus | 825.05 Mn | 789.21 Mn | 90.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 177,000.00 |
| Dec 31, 2025 | 177,000.00 |
| Dec 31, 2024 | 76,000.00 |
| Dec 31, 2024 | 76,000.00 |
| Sep 28, 2024 | 6.50 Mn |
| Sep 28, 2024 | 6.50 Mn |
| Dec 31, 2023 | 257,000.00 |
| Dec 31, 2023 | 257,000.00 |
| Dec 31, 2022 | 350,000.00 |
| Dec 31, 2022 | 350,000.00 |
| Dec 31, 2021 | 82,000.00 |
| Dec 31, 2021 | 82,000.00 |
| Dec 31, 2020 | 81,000.00 |
| Dec 31, 2020 | 81,000.00 |